To describe the natural history of SARS-CoV-2 infection in patients with hypertrophic cardiomyopathy (HCM) compared with a control group and to identify predictors of adverse events.
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry / Gimeno, J.R., Olivotto, I., Rodríguez, A.I., Ho, C.Y., Fernández, A., Quiroga, A., Espinosa, M.A., Gómez-González, C., Robledo, M., Tojal-Sierra, L., Day, S.M., Owens, A., Barriales-Villa, R., Larrañaga, J.M., Rodríguez-Palomares, J., González-Del-Hoyo, M., Piqueras-Flores, J., Reza, N., Chumakova, O., Ashley, E.A., et al.. - In: ESC HEART FAILURE. - ISSN 2055-5822. - STAMPA. - 9:(2022), pp. 2189-2198. [10.1002/ehf2.13964]
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
Olivotto, Iacopo;
2022
Abstract
To describe the natural history of SARS-CoV-2 infection in patients with hypertrophic cardiomyopathy (HCM) compared with a control group and to identify predictors of adverse events.
| File | Dimensione | Formato | |
|---|---|---|---|
|
impact_sars_cov_2_infection_patients_hypertrophic_cardiomyopathy_results_an_international_multicentre_registry_2022.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.56 MB
Formato
Adobe PDF
|
1.56 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
